| Literature DB >> 34872054 |
Fiorella Krapp1, Claudia Rondon1, Catherine Amaro2, Evelyn Barco-Yaipén3, María Valera-Krumdieck4, Rubén Vásquez4, Alexander Briones5, Martin Casapia5, Antonio Burgos6, Favio Sarmiento López6, Pierina Vilcapoma7, Roberto Díaz Sipión8, Miguel Villegas-Chiroque8, Kelly Castillo9, Jimena Pino-Dueñas10, Edwin Cuaresma Cuadros11, Hugo Alpaca-Salvador12, René Campana13, Teresa Peralta Córdova14, Elizett Sierra Chavez15, Carla Aguado Ventura16, Marjan Peeters17, Jan Jacobs17,18, Coralith Garcia1,2.
Abstract
Correct processing of blood cultures may impact individual patient management, antibiotic stewardship, and scaling up of antimicrobial resistance surveillance. To assess the quality of blood culture processing, we conducted four assessments at 16 public hospitals across different regions of Peru. We assessed the following standardized quality indicators: 1) positivity and contamination rates, 2) compliance with recommended number of bottles/sets and volume of blood sampled, 3) blood culture utilization, and 4) possible barriers for compliance with recommendations. Suboptimal performance was found, with a median contamination rate of 4.2% (range 0-15.1%), with only one third of the participating hospitals meeting the target value of < 3%; and a median positivity rate of 4.9% (range 1-8.1%), with only 6 out of the 15 surveilled hospitals meeting the target of 6-12%. None of the assessed hospitals met both targets. The median frequency of solitary blood cultures was 71.9% and only 8.9% (N = 59) of the surveyed adult bottles met the target blood volume of 8 - 12 mL, whereas 90.5% (N = 602) were underfilled. A high frequency of missed opportunities for ordering blood cultures was found (69.9%, 221/316) among patients with clinical indications for blood culture sampling. This multicenter study demonstrates important shortcomings in the quality of blood culture processing in public hospitals of Peru. It provides a national benchmark of blood culture utilization and quality indicators that can be used to monitor future quality improvement studies and diagnostic stewardship policies.Entities:
Mesh:
Year: 2021 PMID: 34872054 PMCID: PMC8832895 DOI: 10.4269/ajtmh.21-0770
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 2.345